Manufacturing A Donor Lymphocyte Product Depleted Of TCR-αβ T Cells And CD19+ B Cells For Prophylactic Infusion Following Allogeneic Stem Cell Transplantation

Autor: Otegbeye, F., Ramsey, C., Fox, R., Turney, T.L., Garcia, M., Reese-Koç, J., Meyerson, H., de Lima, M.
Zdroj: In Cytotherapy May 2020 22(5) Supplement:S134-S134
Databáze: ScienceDirect